This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 2Al Sayah, Fatima
- 1Adame Perez, Stephany
- 1Al-Adra, David P.
- 1Albalawi, Zaina H
- 1Anderson, Sarah J
- 1Asaad, Ghada A
- 8Department of Agricultural, Food, and Nutritional Science
- 6Department of Surgery
- 4School of Public Health
- 3Department of Medicine
- 3Faculty of Pharmacy and Pharmaceutical Sciences
- 3School Public Health Sciences
- 2Johnson, Jeff A. (School of Public Health Sciences, University of Alberta)
- 2Williams, Beverly (Faculty of Nursing, University of Alberta)
- 1Al Hamarneh, Yazid (Pharmacology)
- 1Anderson, Colin (Medical Microbiology and Immunology and Surgery)
- 1Baldwin, Troy (Medical Microbiology and Immunology)
- 1Chan, Catherine (Agricultural, Food and Nutritional Sciences)
-
Clinical and Translational Studies Advancing Clinical Implementation of Stem Cell-Derived Islet Transplantation
DownloadSpring 2024
Twenty-years ago Shapiro et al. revolutionized islet transplantation (ITx), realizing the potential for a cell-based diabetes treatment. Despite improvements, ITx remains restricted by organ donor limitations and immunosuppression. Stem cell (SC)-derived ITx (SC Tx) could eliminate these...
-
Spring 2021
As one of the most accessible primary health care providers, pharmacists are in an excellent position to provide primary health care services. Although slow, the current transition from a dispensing-centered (transaction-based) pharmacy approach to a patient-centered (patient care based) approach...
-
Non-fasting remnant cholesterol as a predictor for cardiovascular disease risk in Canadians with and without diabetes mellitus in the Alberta’s Tomorrow Project
DownloadFall 2022
Cardiovascular disease (CVD) is a leading cause of death in Canada, and its risk of development is 3 times greater in those with diabetes mellitus (DM). Fasting low-density lipoprotein cholesterol (LDL-C) is the traditional lipid biomarker used in CVD risk assessment. While lowering LDL-C does...
-
Heart Failure Related Outcomes in Patients within a Specialized Clinic-Based Cohort and a Population Level Cohort: Emphasis on Diabetes
DownloadFall 2024
Diabetes mellitus (DM) is a well-established risk factor for adverse prognosis in patients with heart failure (HF). Outcomes in this patient population have not been thoroughly investigated in specialized heart function clinics (HFC). Recently, sodium-glucose cotransporter-2 (SGLT2) inhibitors...
-
Vitamin D Status and Health-care Outcomes in an Ambulatory Population of Patients with Diabetes and Chronic Kidney disease: A Five-year Follow-up.
DownloadSpring 2018
Vitamin D (VitD) deficiency is a prevalent condition in Canada, especially in northern latitudes where sunlight exposure is limited. Elderly patients especially those with chronic conditions such as Diabetes Mellitus (DM) and Chronic Kidney Disease (CKD) have a higher risk of developing vitD...
-
Drug Exposure Definition and Healthy User Bias Impacts on the Evaluation of Oral Anti Hyperglycemic Therapies
DownloadFall 2017
Accurate estimation of medication use is an essential component of any pharmacoepidemiological research as exposure misclassification will threaten study validity and lead to spurious associations. Many pharmacoepidemiological studies use simple definitions, such as the categorical “any versus no...
-
The impact of diabetic foot problems on health-related quality of life of people with diabetes
DownloadSpring 2017
People with diabetes are at a greater risk of developing foot complications and this chronic condition continues to be the leading cause of non-traumatic amputations in Canada. The purpose of this thesis was to examine the impact diabetic foot problems have on health-related quality of life of...
-
Fall 2024
Obesity is a major public health problem since it is associated with different complications, including cardiovascular diseases, cancer, type 2 diabetes (T2D), and a higher risk of infections. This is due in part to the fact that obesity is characterized by the presence of chronic low-grade...
-
Fall 2024
Background: Dyslipidemia is a common characteristic in both diabetes and obesity, due in part to elevated triglyceride (TG)-rich very-low density lipoprotein (VLDL-TG) secretion from the liver. Excessive levels and/or action of glucocorticoids (GCs) is also observed in these metabolic diseases...
-
Characterization of Human Pancreatic Beta-cell Progenitors as a Means to Alleviate the Shortage of Donor Tissue for Islet Transplantation
DownloadFall 2012
The current shortage of islet tissue from cadaveric human donors is not sustainable and will preclude islet transplantation from becoming a widespread therapeutic treatment for those with type 1 diabetes. A potential alternative source of tissue may be through isolating, expanding, and...